
- Volume 0 0
One-Day Treatment of Herpes Drug Found Effective
Famciclovir (Famvir), in a single-dosetreatment, has been proven to stop theprogression to a full-blown outbreak ofrecurrent genital herpes (rGH) as well asto shorten the duration of the outbreak.Thus far, famciclovir is the only treatmenteffective for rGH in a single dose. A multicenter,randomized, double-blind,placebo-controlled study compared the1-g dose for 1-day famciclovir with placebo.When patients with rGH initiatedtreatment with famciclovir within 6hours of the first sign of outbreak, famciclovirreduced healing time of nonabortedlesions by 2 days. A higher percentageof patients experienced aborted lesionsin the famciclovir group (23.3%) than inthe placebo group (12.7%). In fact,patients taking famciclovir experienced areduction in duration of all symptoms:itching, pain, burning, tingling, and tenderness—3.3 days versus 5.4 days in theplacebo group. Lead investigator FredAoki, MD, of the University of Manitoba(Canada), concluded, "Famvir was effectivein a single-day dose because it provideda full course of therapy upfrontwhen the virus is most active."
Ms. Farley is a freelance medicalwriter based in Wakefield, RI.
Articles in this issue
over 19 years ago
British Poll Shows People Denying Weight Problemsover 19 years ago
Suing a Lawyer for Malpractice?over 19 years ago
Pharmacists—Cops or Not? (Part 1)over 19 years ago
Can You Read These Rxs?over 19 years ago
Alternative Measures for Treating Pediculosisover 19 years ago
Compounding Hotlineover 19 years ago
Obesity May Lead to Kidney Failureover 19 years ago
Body Fat Associated with Alzheimer's Proteinover 19 years ago
Midlife Obesity May Cause Heart Diseaseover 19 years ago
The Evolution of Imprint IdentificationNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.



















































































































































































































